Dr Reddys Laboratories Share Price Today - Live Blog for July 08, 2025

With a -0.02% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,284.00. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.3300, while the industry PE is 35.3587.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.05% upswing, and it's currently trading at ₹1,284.20 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.20%, reaching the current market price of ₹1,284.10. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.12%, and as of now, it's trading at ₹1,282.75 per share. This upward trajectory is attracting keen interest from investors.

Following a noteworthy 0.11% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,282.30. When it comes to valuation, this stock has a PE ratio of 19.3300, with the industry PE ratio at 35.3587.

Dr Reddys Laboratories Ltd's share price has fallen by -0.16%, a situation worth noting. At present, the stock is trading at ₹1,280.90. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.3300, while the industry PE ratio is 35.3587.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.19% upswing, and it's currently trading at ₹1,284.80 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd experienced a substantial 0.19% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,284.80, making it an appealing option for investors.

Dr Reddys Laboratories Ltd's share price remained unchanged, indicating a period of stability in the market. As of now, the stock is still trading at ₹1,281.00. This static phase might encourage investors to assess their long-term strategies.

Dr Reddys Laboratories Ltd stock remained unchanged, maintaining its position at ₹1,281.00. During this period of price stability, investors can assess the stock's competitive advantages and market positioning.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.21% increase. Presently, it is actively trading at ₹1,281.00.

With a -0.11% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,278.20. The stock is currently trading at a PE of 19.3300, while the industry PE is 35.3587, prompting investors to assess its value proposition.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.02% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,279.65 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.08%, reaching the current market price of ₹1,278.70. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Demonstrating a commendable 0.17% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,277.70. In terms of valuation, the stock maintains a PE ratio of 19.3300, while the industry PE ratio stands at 35.3587.

Dr Reddys Laboratories Ltd witnessed a substantial 0.05% increase in its share price and is currently trading at ₹1,275.55. This remarkable performance has caught the eye of investors.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.03%. At this moment, it's actively trading at ₹1,275.30, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd share price surged by 0.01%. With its current market price standing at ₹1,279.25 per share, this stock is garnering increased attention from the investment community.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.01% gain, with the share price now at ₹1,279.25. Notably, the stock's PE ratio stands at 19.3300, and its Return on Equity (ROE) is 16.8559%.

With a -0.40% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,279.10. Investors should examine the factors driving this decline. The stock's PE ratio is 19.3300, whereas the industry PE ratio stands at 35.3587.

The stock of Dr Reddys Laboratories Ltd suffered a -0.16% decline, and it currently trades at ₹1,285.10 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's share price has dropped by -0.16%, a development that warrants careful analysis. Presently trading at ₹1,285.10, investors are assessing whether this presents an opportunity or a risk.

The stock of Dr Reddys Laboratories Ltd suffered a -0.23% decline, and it currently trades at ₹1,287.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.02% increase and currently trading at ₹1,289.55 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd observed a remarkable 0.02% surge in its share price and is presently trading at ₹1,290.00. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd experienced a -1.89% dip in its share price and is currently trading at ₹1,289.40. The stock has a PE ratio of 19.3300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.